MOLECULAR CELL BIOLOGY OF AMYLOID PRECURSOR PROTEIN
MOLECULAR CELL BIOLOGY OF AMYLOID PRECURSOR PROTEIN
批准号:
3121187
负责人:
WILLIAM L KLEIN
金额:
$9.57万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-05-01 至 1994-04-30
关键词:
Alzheimer's disease aluminum amyloid proteins antibody axon calcium cell adhesion cell adhesion molecules cell death cell membrane cytoskeleton dendrites electron microscopy glucose growth cones heat stimulus hypoxia laboratory rabbit molecular biology neurogenesis neurons oxidation physiologic stressor protein purification protein structure protein structure function receptor stress stress proteins tissue /cell culture transmission electron microscopy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The long-range goal of this work concerns molecular mechanisms of cell
death in Alzheimer's disease (AD). Its immediate focus is to study the
molecular cell biology of amyloid precursor protein (APP). The
cytoarchitectural nature of APP in situ, its functional role, and the
factors influencing its expression are essentially unknown. The proposed
aims address these gaps and, additionally, will help to establish a
useful new model for experimental studies of AD neuropathogenesis.
AIM #1- To characterize the structural biology of APP at cell and
extracellular surfaces, focusing on tests of the hypothesis that APP may
be a cell adhesion molecule. While the cellular function of APP is
unknown, one major hypothesis based on sequence analysis is that this
protein is a cell adhesion molecule. To test this hypothesis directly,
and to characterize the structural biology of the APP molecule in situ,
we recently have developed a whole mount EM-immunogold method for
studying APP expression in cultured human nerve cell lines. Based on our
pilot studies, we propose (1) To verify and extend characterization of
the relationship between APP forms and adhesive microfibrils found at
cell and extracellular surfaces, applying whole mount transmission
electron microscopy-immunogold protocols to SHSY5Y human neuroblastoma
cell cultures. (2) To evaluate the adhesive role of APP, using paradigms
that test adhesion-linked functions such as neurite extension and growth
cone motility (3) To provide initial characterization of a postulated APP
receptor, using isolation protocols based on the adhesive properties of
APP.
AIM #2- To evaluate the influence of cellular stress factors on
APP expression. The APP promoter is known to have multiple control
elements, including a stress-related heat shock sequence. Experiments
therefore have been designed to study APP expression in response to
external influences that can stress nerve cells. Six factors
incriminated directly or indirectly in the pathogenesis of AD will be
studied (heat shock, Ca++ overload, glucose withdrawal, hypoxia, oxidant
injury, and aluminum). The distribution of specific APP forms on cell
and culture surfaces will be compared using imaging techniques; the
levels of APP forms associated with cells and culture substratum will be
measured by quantitative immunoblots. The data will provide essential
tests of the hypothesis that cell stress causes significant changes or
anomalies in APP expression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Physiological role of naturally-occuring amyloid beta oligomers
-
批准号:9759747
-
项目类别:
-
资助金额:$19.29万
-
财政年份:2018
-
负责人:WILLIAM L KLEIN
-
依托单位:
Development of a non-fibrillic amyloid-beta oligomer selective positron emission tomography imaging diagnostic for Alzheimer.
-
批准号:9202960
-
项目类别:
-
资助金额:$22.22万
-
财政年份:2016
-
负责人:WILLIAM L KLEIN
-
依托单位:
A novel, nanoparticle-based molecular MRI probe for early Alzheimer's diagnostics
-
批准号:8842908
-
项目类别:
-
资助金额:$18.73万
-
财政年份:2014
-
负责人:WILLIAM L KLEIN
-
依托单位:
A novel, nanoparticle-based molecular MRI probe for early Alzheimer's diagnostics
-
批准号:8683797
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2014
-
负责人:WILLIAM L KLEIN
-
依托单位:
Alzheimer's Drug Discovery Using Unique Nanotechnology Platform
-
批准号:8548221
-
项目类别:
-
资助金额:$18.44万
-
财政年份:2012
-
负责人:WILLIAM L KLEIN
-
依托单位:
Alzheimer's Drug Discovery Using Unique Nanotechnology Platform
-
批准号:8446087
-
项目类别:
-
资助金额:$24.74万
-
财政年份:2012
-
负责人:WILLIAM L KLEIN
-
依托单位:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
-
批准号:7615522
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2007
-
负责人:WILLIAM L KLEIN
-
依托单位:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
-
批准号:7184209
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2007
-
负责人:WILLIAM L KLEIN
-
依托单位:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
-
批准号:7470605
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2007
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimers Disease pathology
-
批准号:6678227
-
项目类别:
-
资助金额:$33.05万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimer's Disease pathology
-
批准号:7805554
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs)in Alzheimers Disease pathology
-
批准号:6931646
-
项目类别:
-
资助金额:$34.61万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimer's Disease pathology
-
批准号:7467169
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs)in Alzheimers Disease pathology
-
批准号:6795925
-
项目类别:
-
资助金额:$34.62万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
Abeta oligomers (ADDLs) in Alzheimer's Disease pathology
-
批准号:7595791
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2003
-
负责人:WILLIAM L KLEIN
-
依托单位:
NEUROLOGICAL DEFICITS DUE TO TOXIC A BETA OLIGOMERS
-
批准号:6233462
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2001
-
负责人:WILLIAM L KLEIN
-
依托单位:
NEUROLOGICAL DEFICITS DUE TO TOXIC A BETA OLIGOMERS
-
批准号:6615732
-
项目类别:
-
资助金额:$29.23万
-
财政年份:2001
-
负责人:WILLIAM L KLEIN
-
依托单位:
NEUROLOGICAL DEFICITS DUE TO TOXIC A BETA OLIGOMERS
-
批准号:6532552
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2001
-
负责人:WILLIAM L KLEIN
-
依托单位:
MORPHOGENIC SIGNAL TRANSDUCTION IN NEURONS
-
批准号:2703069
-
项目类别:
-
资助金额:$19.22万
-
财政年份:1996
-
负责人:WILLIAM L KLEIN
-
依托单位:
MORPHOGENIC SIGNAL TRANSDUCTION IN NEURONS
-
批准号:2273680
-
项目类别:
-
资助金额:$18.86万
-
财政年份:1996
-
负责人:WILLIAM L KLEIN
-
依托单位:
国内基金
海外基金
Aluminum/CFRP 混合管界面分层对渐进折叠机制影响研究
-
批准号:ZCLQN26E0501
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:沈勇
-
依托单位: